GSK Consumer Split Set For July, With Emerging Markets And Switch To Drive Growth

01 Mar 2022

GSK will spin-off its consumer health business in July under the name Haleon. The standalone operation expects to outpace market growth rates by expanding in emerging markets, tapping into consumer demand for more natural products and delivering two Rx-to-OTC switches in the US.

Launch Plans words stamped in red ink on yellow envelope offering advice, information — • Source: Shutterstock

Rx-to-OTC switch, meeting demand for more natural OTC products and expanding in emerging markets will help GlaxoSmithKline’s standalone consumer health business grow faster than the market when it launches later this year, according to CEO designate Brian McNamara.

Speaking at GSK’s capital markets day, McNamara said the standalone business – which will be called Haleon – was expected...